543916 — Hemant Surgical Industries Cashflow Statement
0.000.00%
- IN₹1.07bn
- IN₹1.14bn
- IN₹1.06bn
- 33
- 60
- 15
- 26
Annual cashflow statement for Hemant Surgical Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 8.54 | 15.2 | 34 | 101 | 128 |
Depreciation | |||||
Non-Cash Items | 3.43 | 16.5 | 33 | 29.1 | -1.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.385 | -40.7 | 74.3 | -78.2 | -212 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 16.5 | -2.71 | 155 | 60 | -75.6 |
Capital Expenditures | -27.1 | -23.9 | -4.23 | -39.3 | -55.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 9.02 | 0.599 | 17.5 | 9.61 | -34.5 |
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -18.1 | -23.3 | 13.3 | -29.7 | -89.7 |
Financing Cash Flow Items | -7.62 | -1.13 | -46.7 | -19.1 | -9.45 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 23.9 | 5.17 | -111 | -3.94 | 212 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 22.3 | -20.8 | 57 | 26.3 | 47.1 |